SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-13-000238
Filing Date
2013-02-14
Accepted
2013-02-14 10:03:07
Documents
2
Period of Report
2013-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DELMAR PHARMACEUTICALS, INC. FORM 8-K form8k.htm 8-K 43515
2 EXHIBIT 3.1 ex31.htm EX-3.1 6995
  Complete submission text file 0001013762-13-000238.txt   52104
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54801 | Film No.: 13607147
SIC: 2834 Pharmaceutical Preparations